Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45
Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $45.
Stocks · News reference
8-K filing — OMNICELL, INC. (OMCL)
Filed: 2026-07-01 AccNo: 0001104659-26-079606 Size: 231 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.
Keybanc Maintains Overweight on Omnicell, Lowers Price Target to $65
Omnicell shares are trading lower. The company reported Q2 financial results and issued Q3 guidance below analyst estimates.